Antazoline
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
|
N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-N-(phenylmethyl)aniline
|
|
| Clinical data | |
| Trade names | Vasocon-a |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Routes of administration |
Topical (nasal, eye drops) |
| Identifiers | |
| CAS Number | 91-75-8 |
| ATC code | R01AC04 R06AX05 |
| PubChem | CID 2200 |
| IUPHAR/BPS | 7116 |
| DrugBank | DB08799 |
| ChemSpider | 2115 |
| UNII | DHA8014SS1 |
| KEGG | D07458 |
| ChEBI | CHEBI:84115 |
| ChEMBL | CHEMBL1305 |
| Chemical data | |
| Formula | C17H19N3 |
| Molar mass | 265.353 g/mol |
|
|
|
|
| (verify) |
Antazoline is a 1st generation antihistamine with also anticholinergic properties used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.[1]
References[edit]
|
|
|
| This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |

